Wall Street analysts predict that Surgery Partners, Inc. (NASDAQ:SGRY – Get Rating) will announce ($0.03) earnings per share for the current fiscal quarter, Zacks Investment Research reports. Five analysts have provided estimates for Surgery Partners’ earnings, with estimates ranging from ($0.07) to ($0.01). The company is expected to announce its next earnings report on Monday, January 1st.
According to Zacks, analysts expect that Surgery Partners will report full year earnings of $0.29 per share for the current fiscal year, with EPS estimates ranging from $0.05 to $0.48. For the next financial year, analysts anticipate that the business will post earnings of $0.66 per share, with EPS estimates ranging from $0.38 to $0.83. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that that provide coverage for Surgery Partners.
Surgery Partners (NASDAQ:SGRY – Get Rating) last released its quarterly earnings results on Tuesday, May 3rd. The company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.02. Surgery Partners had a negative net margin of 1.63% and a negative return on equity of 0.46%. During the same quarter last year, the firm earned ($0.40) EPS.
Shares of NASDAQ:SGRY traded up $0.78 during midday trading on Wednesday, hitting $39.83. The company’s stock had a trading volume of 523,977 shares, compared to its average volume of 445,316. The business’s 50 day simple moving average is $51.28 and its 200 day simple moving average is $49.69. The company has a debt-to-equity ratio of 1.50, a quick ratio of 1.61 and a current ratio of 1.73. The company has a market cap of $3.58 billion, a P/E ratio of -75.15, a price-to-earnings-growth ratio of 10.78 and a beta of 2.76. Surgery Partners has a 12-month low of $36.96 and a 12-month high of $69.58.
In other Surgery Partners news, CFO David T. Doherty sold 3,678 shares of Surgery Partners stock in a transaction on Tuesday, March 15th. The shares were sold at an average price of $49.29, for a total value of $181,288.62. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider George Goodwin sold 25,525 shares of Surgery Partners stock in a transaction on Thursday, April 21st. The stock was sold at an average price of $62.58, for a total transaction of $1,597,354.50. Following the completion of the transaction, the insider now directly owns 57,990 shares of the company’s stock, valued at approximately $3,629,014.20. The disclosure for this sale can be found here. Insiders sold 116,220 shares of company stock worth $6,300,372 in the last 90 days. 3.30% of the stock is currently owned by insiders.
Several hedge funds and other institutional investors have recently modified their holdings of SGRY. Signaturefd LLC bought a new stake in Surgery Partners in the fourth quarter worth about $63,000. PNC Financial Services Group Inc. grew its stake in Surgery Partners by 34.7% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,195 shares of the company’s stock valued at $66,000 after acquiring an additional 308 shares in the last quarter. Nisa Investment Advisors LLC grew its stake in Surgery Partners by 444.4% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,960 shares of the company’s stock valued at $84,000 after acquiring an additional 1,600 shares in the last quarter. Allspring Global Investments Holdings LLC purchased a new position in Surgery Partners during the 4th quarter valued at about $92,000. Finally, Balyasny Asset Management LLC bought a new stake in shares of Surgery Partners in the 3rd quarter valued at approximately $203,000.
Surgery Partners Company Profile (Get Rating)
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
- Get a free copy of the StockNews.com research report on Surgery Partners (SGRY)
- Short-Covering Begins In Big Lots
- Agilent Technologies Is Bottoming But Don’t Buy It Yet
- Institutions Ring The Register On Toll Brothers Stock
- Dick’s Sporting Goods Falls Flat On Weak Guidance
- Indie Semiconductor Stock is Putting in a Bottom
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.